CoLabs Intl. Corp, established in 2008, is a biotechnology company specializing in the controlled delivery of topical cosmetics and drugs. Their core mission is to advance global health, science, and environmental sustainability through innovative technology and unique absorption-limiting science. CoLabs offers products designed to reduce the unwanted absorption of drugs into the skin and the environment, with a strong focus on preventive medicine using targeted technologies.
Notable affiliated individuals include key researchers and scientists who have contributed to the development of their proprietary QuantaSphere® technology. CoLabs has attracted significant investment from industry leaders in biotechnology and pharmaceuticals. The company has achieved recognition for its advanced research and consumer acceptance, making a substantial impact on the market for topical drug delivery systems.
